This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignees: George Mason Research Foundation, Inc., George Mason University, University of Pennsylvania. Active years: 2025-2026.
Company Filing History:
1 out of 2 
1 out of 270 
1 out of 2,651 
Years Active: 2025-2026
Title: Manuel Carrasco: Innovator in Lipid Nanoparticle Manufacturing
Introduction
Manuel Carrasco is a notable inventor based in Fairfax Station, VA (US). He has made significant contributions to the field of lipid nanoparticle manufacturing, particularly in enhancing the potency of nucleic acid loaded lipid nanoparticles (naLNPs). His innovative methods have the potential to revolutionize the pharmaceutical industry by improving the delivery of nucleic acids.
Latest Patents
Carrasco holds a patent for "Methods of lipid nanoparticle manufacture and compositions derived therefrom." This patent discloses methods aimed at increasing the potency of naLNPs through novel and superior manufacturing techniques. The disclosed methods address major technical challenges and high costs associated with previous LNP manufacturing techniques. By improving industrial production, these methods provide more potent naLNPs for effective nucleic acid delivery. Specifically, the invention demonstrates increased potency due to enhanced mixing concentration of lipids and mRNA during assembly.
Career Highlights
Throughout his career, Manuel Carrasco has worked with prestigious institutions such as the University of Pennsylvania and George Mason University. His experience in these organizations has contributed to his expertise in lipid nanoparticle technology and its applications in pharmaceuticals.
Collaborations
Carrasco has collaborated with notable colleagues, including Michael Daro Buschmann and Mikell Paige. These partnerships have furthered research and development in the field of lipid nanoparticles.
Conclusion
Manuel Carrasco's innovative work in lipid nanoparticle manufacturing showcases his commitment to advancing pharmaceutical technologies. His patent and collaborations highlight his significant contributions to the field, paving the way for more effective nucleic acid delivery systems.